Elena V. Kudryashova

Prof. Elena V. Kudryashova

Lomonosov Moscow State University, Chemistry Department
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 1996 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
VMVadim V. Mozhaev
Vadim V. Mozhaev
RLReinhard Lange
Reinhard Lange
Elena V. KudryashovaElena V. Kudryashova
Elena V. Kudryashova
CBClaude Balny
Claude Balny


20 July 1997 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
Elena V. KudryashovaElena V. Kudryashova
Elena V. Kudryashova
AGAlexander K. Gladilin
Alexander K. Gladilin
AVAlexander Vakurov
Alexander Vakurov
FHFrederic Heitz
Frederic Heitz
ALAndrey V. Levashov
Andrey V. Levashov
VMVadim V. Mozhaev
Vadim V. Mozhaev

23 April 2003 in European Biophysics Journal
Verified
Journal Article
Closed access
PDF file
Elena V. KudryashovaElena V. Kudryashova
Elena V. Kudryashova
MMMarcel B. J. Meinders
Marcel B. J. Meinders
AVAntonie J. W. G. Visser
Antonie J. W. G. Visser
AHArie van Hoek
Arie van Hoek
HJHarmen H. J. de Jongh
Harmen H. J. de Jongh

29 August 2017 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
Irina M. Le-DeygenIrina M. Le-Deygen
Irina M. Le-Deygen
ASAnna A. Skuredina
Anna A. Skuredina
IUIgor V. Uporov
Igor V. Uporov
Elena V. KudryashovaElena V. Kudryashova
Elena V. Kudryashova

4 February 2023 in Life
Verified
Journal Article
Open access
PDF file
IZIgor Zlotnikov
Igor Zlotnikov
DSDmitriy A. Streltsov
Dmitriy A. Streltsov
NBNatalya Georgievna Belogurova
Natalya Georgievna Belogurova
Elena V. KudryashovaElena V. Kudryashova
Elena V. Kudryashova
Polymeric micelles combining the advantages of biocompatible poly- and oligosaccharides with classical micellar amphiphilic systems represent a promising class of drug carriers. In this work, micelles based on chitosan (or cyclodextrin) and oleic acid with various modification degrees were synthesized—the most optimal grafting degree is 15–30% in terms of CMC. According to NTA data, micelles have a hydrodynamic diameter of the main fraction of 60–100 nm. The inclusion of the antibacterial agents: moxifloxacin or rifampicin in micelles was studied by FTIR spectroscopy and fluorescence spectroscopy using a pyrene label (using monomer-excimer approach). When aromatic molecules are incorporated into micelles, the absorption bands of C-H bonds of the fatty tails of micelles shift towards smaller wavenumbers, indicating a stabilization of the micelles structure, and the microenvironment of the drug molecule changes according to the low frequencies shift and intensity changes in oscillation frequencies of 1450 cm−1 corresponding to aromatic fragment. Loading of moxifloxacin and rifampicin into micelles leads to a change in the fluorescent properties: a shift of the maximum of fluorescence emission to the long-wavelength region and an increase in the fluorescence anisotropy due to a drastic increase in the hydrodynamic volume of the fluorophore-containing rotating fragment. Using the pyrene label, the critical micelle concentrations were determined: from 4 to 30 nM depending on the polymer composition. Micellar systems enhance the effect of the antibiotic by increasing the penetration into bacterial cells and storing the drug in a protective coat. As a part of the supramolecular structure, the antibiotic remains active for more than four days, while in free form, the activity decreases after two days. In pharmacokinetic experiments, in vivo moxifloxacin in micellar systems show 1.7 times more efficiency compared to free form; moreover, two times higher maximal concentration in the blood is achieved. The advantage of polymer micellar systems in comparison with simple cyclodextrins and chitosan, which do not so significantly contribute to the antibacterial and pharmacokinetic parameters, was shown. Thus, polymeric micelles are one of the key approaches to improving the effectiveness of antibacterial drugs and solving the problems of resistant bacterial infections and multidrug resistance.